IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tang Capital Management LLC

Q4 2019 Holdings

Filed 2020-02-14 | 17 holdings | $837.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Odonate Therapeutics IncCOM676079106$456.7K14,075,26954.6%
Heron Therapeutics Inc(HRTX)COM427746102$117.9K5,017,20314.1%
Rocket Pharmaceuticals Inc(RCKT)COM77313F106$67.5K2,965,4858.1%
Relmada Therapeutics Inc(RLMD)COM75955J402$50.7K1,300,0006.1%
Evolus Inc(EOLS)COM30052C107$32.1K2,635,0003.8%
Anaptysbio Inc(ANAB)COM032724106$30.0K1,843,8143.6%
Avrobio IncCOM05455M100$20.1K1,000,0002.4%
LA Jolla Pharmaceutical Co(LJPC)COM503459604$19.4K4,938,8932.3%
Regeneron Pharmaceuticals(REGN)COM75886F107$16.9K45,0002.0%
Bristol Myers Squibb Co(BMY)COM110122108$7.2K111,8440.9%
Prothena Corp PLC(PRTA)SHSG72800108$6.7K423,8230.8%
G1 Therapeutics Inc(GTHXEUR)COM3621LQ109$4.5K170,0000.5%
Puma Biotechnology Inc(PBYI)COM74587V107$3.1K349,4000.4%
Iveric BIO Inc(OPHTEUR)COM46583P102$2.1K250,0000.3%
Nucana PLCSPONSORED ADR67022C106$1.5K250,0000.2%
Bristol Myers Squibb Co(BMY-R)RIGHT 99/99/9999110122157$337111,8440.0%
Eidos Therapeutics Inc(EIDXGBP)COM28249H104$2173,7830.0%